Shengsong He
- Topics
- NF-κB Signaling Pathways (2 papers)SARS-CoV-2 and COVID-19 Research (1 paper)interferon and immune responses (1 paper)
- Journals
- Cellular and Molecular ImmunologyJournal of Cancer Research and Clinical OncologyJournal of Huazhong University of Science and Technology [Medical Sciences]
- Partner nations
- China
In The Last Decade
Shengsong He
8 papers receiving 47 citations
Peers
Comparison fields: 5 of 41
- Infectious Diseases 18
- Molecular Biology 14
- Epidemiology 12
- Hepatology 10
- Cancer Research 9
Countries citing papers authored by Shengsong He
This map shows the geographic impact of Shengsong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengsong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengsong He more than expected).
Fields of papers citing papers by Shengsong He
This network shows the impact of papers produced by Shengsong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengsong He. The network helps show where Shengsong He may publish in the future.
Co-authorship network of co-authors of Shengsong He
This figure shows the co-authorship network connecting the top 25 collaborators of Shengsong He. A scholar is included among the top collaborators of Shengsong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengsong He. Shengsong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 19 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | Experimental study on the effect of quercetin on schistosome-infected mice with liver fibrosis | 1 |
| 8 | [Inhibition of quercetin on liver fibrosis due to Schistosoma japonicum infection and on the expression of immediate early gene and metalloproteinase 1 inhibitor in liver tissue of mice]. | 3 |
About Shengsong He
Shengsong He is a scholar working on Hepatology, Cancer Research and Health, having authored 8 papers that have together received 48 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Hepatology (10 citations), Infectious Diseases (18 citations) and Cancer Research (9 citations). Shengsong He has collaborated with scholars based in China. Frequent co-authors include Juanjuan Xu, Chen Feng, Ji-Hua Dong, Xin Zheng, Yongwen He, Baoju Wang, Boyun Liang, Hua Wang, Dongliang Yang and Songbai Wang. Their work appears in journals such as Cellular and Molecular Immunology, Journal of Cancer Research and Clinical Oncology and Journal of Huazhong University of Science and Technology [Medical Sciences].
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.